Level C· Early human research exploring benefitsProspective StudyPubMed

Hypoxia-preconditioned adipose-derived mesenchymal stem cells-derived exosomes transferring H19 obstruct neutrophil extracellular traps formation via HOXA5-mediated inactivation of TLR4/NF-κB/NLRP3 inflammatory signaling

Qian L., Meng X., Fang B., Pi L.

Prospective Study on Diabetic Foot, Chronic Wound, published in J Diabetes Investig (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Diabetes Investig (2026)
Country
Japan
Reported sample size
—
Source database
PubMed
PMID
42257551
DOI
10.1111/jdi.70352

Abstract (original English)

Background Hypoxia-stimulated adipose-derived mesenchymal stem cells (ADSCs)-derived exosomes (Hypo-Exo) have a positive impact on diabetic wound healing. Neutrophil extracellular traps (NETs) can delay wound healing under diabetic hyperglycemia. This study aimed to investigate the mechanisms by which Hypo-Exo influence NETs formation. Methods The dorsal excisional wound model was performed using streptozotocin-induced diabetic mice. Neutrophils were treated with phorbol 12-myristate 13-acetate and Hypo-Exo or ADSCs overexpressing H19 Exo, which were prepared for subsequent exploration. NETs formation was analyzed employing Sytox Green staining and PicoGreen dsDNA assay. Human umbilical vein endothelial cells (HUVECs) were exposed to the culture medium of neutrophils with Hypo-Exo treatment. CD31 and Alpha-Smooth Muscle Actin protein expression were detected by immunofluorescence staining. Long non-coding RNA H19 (H19) expression was evaluated by RNA-FISH analysis. The luciferase reporter gene and RNA immunoprecipitation analysis verified the interactions between miRNA-130a/b-3p (miR-130a/b-3p) and H19 or Homeobox A5 (HOXA5). Results Hypo-Exo promoted diabetic wound healing by repressing excessive NETs formation. Furthermore, Hypo-Exo inhibited Toll-like receptor 4 (TLR4)/Nuclear factor κB (NF-κB) pathway and inactivated NOD-like receptor pyrin domain-containing 3 (NLRP3) infla

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AnimalsExosomesMesenchymal Stem CellsRNA, Long NoncodingNF-kappa BMiceToll-Like Receptor 4Signal TransductionHumansMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research